- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$31.77 BnMarket Estimate, 2026
$32.81 BnMarket Forecast, 2034
$42.40 BnCAGR, 2026–2034
3.26%Global Thyroid Function Tests Devices Market Size, Growth, Trends & Forecast (2026–2034)
The global thyroid function tests devices market size was valued at USD 31.77 billion in 2025, is estimated to reach USD 32.81 billion in 2026, and is projected to scale up to USD 42.40 billion by 2034, registering a compound annual growth rate (CAGR) of 3.26% during the forecast period from 2026 to 2034. Driven by the escalating prevalence of autoimmune and thyroid disorders, rising unhealthy lifestyle habits (such as alcohol and tobacco consumption), and continuous improvements in global diagnostic infrastructure, the market is positioned for steady long-term expansion.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 31.77 Billion
- 2026 Current Valuation: USD 32.81 Billion
- 2034 Forecast Valuation: USD 42.40 Billion
- Compound Annual Growth Rate (CAGR): 3.26% (2026–2034)
- Dominant Disease Indication Segment: TSH Tests (Thyroid Stimulating Hormone) (holding the leading market share due to cost-effectiveness and high efficacy in diagnosing hypothyroidism)
- Fastest-Growing Disease Indication Segment: TSH Tests (projected as the quickest-growing segment backed by the rising global burden of thyroid disorders)
- Dominant Usage Segment: Hospitals (capturing a major share of clinical test procedures)
- Fastest-Growing Usage Segment: Hospitals (projected as the quickest-growing segment due to expanding patient pools and institutional health awareness campaigns)
- Dominant Regional Market: North America (commanding the top market share backed by advanced healthcare infrastructure)
- Fastest-Growing Regional Market: Asia Pacific (projected to record high growth driven by rising disposable incomes, lifestyle changes, and improving healthcare facilities in developing economies)
Core Market Drivers
- Prevalence of Autoimmune Disorders: Increasing pervasiveness of conditions like Hashimoto's thyroiditis leading directly to hypothyroidism.
- Lifestyle Risk Factors: Rising consumption of tobacco and alcohol, alongside growing sedentary habits triggering metabolic and endocrine imbalances.
Primary Market Restraints & Challenges
- Undiagnosed Population: The asymptomatic nature of early-stage thyroid conditions combined with low public awareness in developing regions.
- Quality Concerns: The presence and distribution of fraudulent or bogus testing reagents impacting diagnostic reliability.
Global Thyroid Function Tests Devices Market Segmentation Breakdown
| Segment Category | Largest Segment | Fastest-Growing Segment |
|---|---|---|
| By Disease Indication | TSH Tests (Thyroid Stimulating Hormone Test) | TSH Tests (Thyroid Stimulating Hormone Test) |
| By Usage | Hospitals | Hospitals |
| By Region | North America | Asia Pacific |
Major Industry Players Profiled
Key enterprises shaping the global thyroid function tests devices market include Beckman Coulter, Siemens Healthcare Diagnostics, bioMérieux Inc., DiaSorin S.p.A., and IBL-America.
Global Thyroid Function Tests Devices Market Size
The size of the global thyroid function tests devices market was worth USD 31.77 billion in 2025. The global market is anticipated to grow at a CAGR of 3.26% from 2026 to 2034 and be worth USD 42.40 billion by 2034 from USD 32.81 billion in 2026.
MARKET DRIVERS
Rising Autoimmune Diseases and Unhealthy Habits Drive Demand for Thyroid Function Tests
Thyroid function tests are blood tests performed to check your thyroid gland's chemicals (hormones). Several thyroid function tests also indicate the level of a hormone secreted by the pituitary gland in your brain, which acts on your thyroid gland.
The increasing consumption of alcohol and tobacco is another major factor propelling the thyroid function test market. The rising prevalence of autoimmune diseases is another crucial factor driving the thyroid function test market's growth across the projected timeframe. Autoimmune disorders develop when the immune system produces antibodies that attack its own body. Hashimoto's thyroiditis is an autoimmune disease that is also a significant factor leading to hypothyroidism. Hence, increasing the pervasiveness of such autoimmune conditions will propel market growth.
MARKET RESTRAINTS
Low Awareness, Lack of Specialists, and Bogus Reagents Hamper Thyroid Test Market Growth
The asymptomatic nature of thyroid diseases leads to a larger undiagnosed population, one of the significant growth-restricting factors. Besides, the lack of endocrinologists in various regions worldwide is estimated to restrict market growth. Low awareness about thyroid conditions and symptoms in developing countries also leads to minimal diagnosis, which is expected to hamper the development of the thyroid function test market globally. Moreover, the use of fraudulent or bogus reagents in tests is also expected to lower the test's quality, thereby hindering the market's growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Disease Indication, Usage, and Region. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | |
| Market Leaders Profiled | Beckman Coulters, Siemens Healthcare Diagnostics, bioMérieux Inc., DiaSorin S.p.A, IBL-America, and Others. |
SEGMENTAL ANALYSIS
By Disease Indication Insights
Based on the disease indication, the TSH segment is projected to lead the global market. It is expected to be the fastest-growing segment during the forecast period due to the growing burden of thyroid disorders globally. The cost-effectiveness and efficacy of TSH in diagnosing hypothyroidism are favoring the market growth.
By Usage Insights
Based on the usage, the hospital segment is projected to be the fastest-growing segment in the global thyroid function tests market during the forecast period. The growing patient pool, rise in clinical tests implemented in hospitals, and the escalating number of healthcare awareness campaigns among the public organized by the governments and hospitals, support the segment’s growth.
REGIONAL ANALYSIS
North America and Europe led the global thyroid function tests market in market share. North America dominated the global thyroid function test market in 2019 due to advanced healthcare infrastructure in North American countries such as the US and Canada.
Europe was the second-leading market for thyroid function tests in 2024 due to a well-established network of major players. Hence, it extends fewer growth opportunities and business development for new entrants. Globally, it is estimated that 1 billion people are prone to thyroid goiter.
The Asia Pacific, especially Japan, is predicted to grow significantly and contribute to the global thyroid function tests market value, showing a high CAGR during the forecast period, 2021 to 2026. The Asia Pacific is expected to observe significant growth in the thyroid function test market during the analysis period. High growth can be attributed to the middle-class population's increasing disposable income and improving healthcare infrastructure in developing countries such as India.
Moreover, the rising prevalence of sedentary lifestyles in countries such as Japan and China is another growth-propelling factor, boosting the thyroid function test market demand. Latin America is likely to be a lucrative market during the forecast period. Cumulatively, Latin America and the Asia Pacific accounted for 25.1% of the global market in 2019. The Middle East & Africa market is expanding at a sluggish pace due to slow economic growth, limited awareness, and low per capita income.
KEY MARKET PLAYERS
Some of the most promising companies leading the global thyroid function test devices market profiled in this report are
- Beckman Coulter
- Siemens Healthcare Diagnostics
- bioMérieux Inc.
- DiaSorin S.p.A.
- IBL-America
MARKET SEGMENTATION
This research report on the global thyroid function test devices market has been segmented and sub-segmented based on disease indication, usage, and region.
By Disease indication
- TSH Tests (Thyroid Stimulating Hormone Test)
- FT4 Tests (Free T4)
- FT3 Tests (Free T3)
By Usage
- Hospitals
- Acute Care Centers
- Diagnostic Laboratories
- Clinics
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa